User Posts: Diane Caldwell
0
1186-P: Implementing a Community Health Worker-Driven Approach to Tackle Racial Disparities in Youth Diabetes Technology Usage
0

Reading Roadmap1186-P: Implementing a Community Health Worker-Driven Approach to Tackle Racial Disparities in Youth Diabetes Technology UsageKey ...

0
1185-P: Gender-Based Variations in Sleep Disturbances Among Adolescents with Type 1 Diabetes (T1D)
0

Reading Roadmap1185-P: Gender-Based Variations in Sleep Disturbances Among Adolescents with Type 1 Diabetes (T1D)Key TakeawaysIntroduction: Unraveling the ...

0
Understanding Cognitive Impairments in Youth with Type 2 Diabetes through Brain Network Analysis via Functional Magnetic Resonance Imaging
0

Reading RoadmapUnderstanding Cognitive Impairments in Youth with Type 2 Diabetes through Brain Network Analysis via Functional Magnetic Resonance ImagingKey ...

0
1150-P: Gender Differences in the Association of Obesity and Blood Sugar Imbalance with Bone Structure in Young People
0

Reading Roadmap1150-P: Gender Differences in the Association of Obesity and Blood Sugar Imbalance with Bone Structure in Young PeopleKey TakeawaysIntroduction: ...

0
Unveiling USP2 Substrates’ Role in Thermogenesis through Proteome-Wide Analysis and EBF2 Stabilization
0

Reading RoadmapUnveiling USP2 Substrates' Role in Thermogenesis through Proteome-Wide Analysis and EBF2 StabilizationKey TakeawaysIntroduction: Unraveling the ...

0
1149-P: Correlation Between Childhood and Adolescent Diet and Late Adolescent Insulin Resistance in Project Viva Study
0

Reading Roadmap1149-P: The Link Between Childhood and Adolescent Diet and Late Adolescent Insulin Resistance in Project Viva StudyKey TakeawaysIntroduction: ...

0
1122-P: Scheduled Post-Discharge Appointments and Their Impact on Clinical Outcomes in Low Socioeconomic Status Community Patients with Diabetes
0

Reading Roadmap1122-P: Scheduled Post-Discharge Appointments and Their Impact on Clinical Outcomes in Low Socioeconomic Status Community Patients with ...

0
1121-P: Protocol for Diabetes Screening Led by Nurses
0

Reading Roadmap1121-P: A Revolutionary Protocol for Diabetes Screening Led by NursesKey TakeawaysIntroduction: The Rising Tide of Diabetes and the Need for ...

0
1120-P: The Danish Diabetes Dashboard – A Comprehensive Tool for Enhancing Diabetes Care Quality
0

Reading Roadmap1120-P: The Danish Diabetes Dashboard - A Comprehensive Tool for Enhancing Diabetes Care QualityKey TakeawaysIntroduction: Revolutionizing ...

0
Vascular Endothelium-Specific ROCK2 Deficiency: A Potential Inhibitor of Obesity Progression Through Adipocyte Browning
0

Reading RoadmapVascular Endothelium-Specific ROCK2 Deficiency: A Potential Inhibitor of Obesity Progression Through Adipocyte BrowningKey ...

0
1083-P: Obstacles Preventing Insulin Pump Adoption Among Adults with Type 1 Diabetes
0

Reading Roadmap1083-P: Overcoming the Barriers to Insulin Pump Adoption Among Adults with Type 1 DiabetesKey TakeawaysIntroduction: The Challenge of Insulin ...

0
1082-P: Impact of Online Clinician Education on Obesity Management Practices for Patients With and Without Type 2 Diabetes
0

Reading Roadmap1082-P: The Influence of Online Clinician Education on Obesity Management Practices for Patients With and Without Type 2 DiabetesKey ...

0
1081-P: The Impact of Web-Based Curriculum on Enhancing Understanding, Skills, and Assurance in Staging and Managing Type 1 Diabetes
0

Reading Roadmap1081-P: The Impact of Web-Based Curriculum on Enhancing Understanding, Skills, and Assurance in Staging and Managing Type 1 DiabetesKey ...

0
Integration of 1080-P Continuous Glucose Monitor into Primary Healthcare Facilities
0

Reading RoadmapIntegration of 1080-P Continuous Glucose Monitor into Primary Healthcare FacilitiesKey TakeawaysIntroduction: Revolutionizing Diabetes ...

0
1063-P: Enhanced Health Outcomes in All Socioeconomic Groups through Carbohydrate-Restricted Intervention and Continuous Remote Care Over Two Years
0

Reading Roadmap1063-P: Enhanced Health Outcomes in All Socioeconomic Groups through Carbohydrate-Restricted Intervention and Continuous Remote Care Over Two ...

0
1062-P: Peer Coaching Lowers Medication Obstacles in African American Patients with Concurrent Diabetes and Hypertension – Findings from the SEC Study
0

Reading Roadmap1062-P: Peer Coaching Lowers Medication Obstacles in African American Patients with Concurrent Diabetes and Hypertension - Findings from the SEC ...

0
1049-P: Using Machine Learning to Categorize the U.S. Population into Subgroups Based on Social Determinants of Health (SDOH)
0

Reading Roadmap1049-P: Using Machine Learning to Categorize the U.S. Population into Subgroups Based on Social Determinants of Health (SDOH)Key ...

0
1048-P: “Pharmacist Plus” Care Model Proves Financially Sustainable and Enhances Diabetes Treatment Results
0

Reading Roadmap1048-P: "Pharmacist Plus" Care Model Proves Financially Sustainable and Enhances Diabetes Treatment ResultsKey TakeawaysIntroduction: The ...

0
1033-P: Measuring Insulin Price Sensitivity Among Medicare Recipients
0

Reading Roadmap1033-P: Measuring Insulin Price Sensitivity Among Medicare RecipientsKey TakeawaysIntroduction: The Rising Cost of Insulin and Its Impact on ...

0
1032-P: A Randomized Control Trial on the Impact of Behavioral Economics-Based Financial and Social Incentives on Glycemic Control in Newly Diagnosed Type 2 Diabetes Patients
0

Reading Roadmap1032-P: A Groundbreaking Study on the Influence of Behavioral Economics on Glycemic Control in Newly Diagnosed Type 2 Diabetes PatientsKey ...

0
1024-P: Post-Hospital Discharge Continuous Glucose Monitoring from a Distance
0

Reading Roadmap1024-P: Post-Hospital Discharge Continuous Glucose Monitoring from a DistanceKey TakeawaysIntroduction: The Emergence of Remote Continuous ...

0
1015-P: Efficacy and Reception of mySugr PRO, a Spanish-Language Diabetes Control App, Among Hispanic/Latino Adults with Unregulated Type 2 Diabetes
0

Reading Roadmap1015-P: Efficacy and Reception of mySugr PRO, a Spanish-Language Diabetes Control App, Among Hispanic/Latino Adults with Unregulated Type 2 ...

0
1003-P: An Advanced Machine-Learning Model and Enlarged Dataset for Noninvasive Blood Glucose Monitoring
0

Reading Roadmap1003-P: An Advanced Machine-Learning Model and Enlarged Dataset for Noninvasive Blood Glucose MonitoringKey TakeawaysIntroduction: ...

0
947-P: A Look Back at the CGM-Driven Tool for Detecting Missed-Meal Bolus
0

Reading Roadmap947-P: A Look Back at the CGM-Driven Tool for Detecting Missed-Meal BolusKey TakeawaysIntroduction: Unveiling the 947-P ToolUnderstanding the ...

0
946-P: A Comprehensive Study on Mortality and Clinical Outcomes of Insulin Pump Therapy in Type 1 Diabetes Patients
0

Reading Roadmap946-P: A Comprehensive Study on Mortality and Clinical Outcomes of Insulin Pump Therapy in Type 1 Diabetes PatientsKey TakeawaysIntroduction: ...

0
945-P: Evaluating Safety and Blood Sugar Control in Adults with Type 2 Diabetes Participating in a MiniMed Advanced Hybrid Closed-Loop System Trial
0

Reading Roadmap945-P: Evaluating Safety and Blood Sugar Control in Adults with Type 2 Diabetes Participating in a MiniMed Advanced Hybrid Closed-Loop System ...

0
944-P: The Effect of Lowering Salt Intake on Nighttime Urination in Type 2 Diabetes Patients—The TOP-STAR Study
0

Reading Roadmap944-P: The Effect of Lowering Salt Intake on Nighttime Urination in Type 2 Diabetes Patients—The TOP-STAR StudyKey TakeawaysIntroduction: ...

0
943-P: A Retrospective Analysis of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) and its Relation to Polycythemia
0

Reading Roadmap943-P: A Retrospective Analysis of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) and its Relation to PolycythemiaKey TakeawaysIntroduction: ...

0
Renal Effects of Canagliflozin 100 mg and Its Intensification to 300 mg in Type 2 Diabetes Patients: Findings from the INTENSIFY Study
0

Reading RoadmapRenal Effects of Canagliflozin in Type 2 Diabetes Patients: Insights from the INTENSIFY StudyKey TakeawaysIntroduction: Unraveling the Renal ...

0
Correlation Between SGLT2i Duration and Urinary and Genitourinary Tract Infections in Type 2 Diabetes Patients: A Comprehensive Study Across India
0

Reading RoadmapCorrelation Between SGLT2i Duration and Urinary and Genitourinary Tract Infections in Type 2 Diabetes Patients: A Comprehensive Study Across ...

0
Comparative Analysis of Enavogliflozin and Dapagliflozin Efficacy in Type 2 Diabetes Treatment Based on Renal Function: Results from Two Randomized Controlled Trials
0

Reading RoadmapComparative Analysis of Enavogliflozin and Dapagliflozin Efficacy in Type 2 Diabetes Treatment Based on Renal Function: Results from Two ...

0
93-OR: Proliferation of Islet Reactive CD4 T-Cells and Early Disease Progression in Type 1 Diabetes
0

Reading Roadmap93-OR: Proliferation of Islet Reactive CD4 T-Cells and Early Disease Progression in Type 1 DiabetesKey TakeawaysIntroduction: Unraveling the ...

0
939-P: Evaluating the Safety of Recent Glucose Drugs in Adults with Type 2 Diabetes and Mild to Moderate Cardiovascular Risk
0

Reading Roadmap939-P: Evaluating the Safety of Recent Glucose Drugs in Adults with Type 2 Diabetes and Mild to Moderate Cardiovascular RiskKey ...

0
Comparative Efficacy and Safety of SGLT2i and Other Oral Antidiabetic Drugs as Supplementary Therapy to Metformin in Type 2 Diabetes: A Systematic Review and Meta-analysis
0

Reading RoadmapComparative Efficacy and Safety of SGLT2i and Other Oral Antidiabetic Drugs as Supplementary Therapy to Metformin in Type 2 Diabetes: A ...

0
936-P: Impact of SGLT2i and Pioglitazone on FIB-4 Index in Indian Patients with Metabolic Dysfunction Related Steatotic Liver Disease: A Real World Retrospective Study
0

Reading Roadmap936-P: Impact of SGLT2i and Pioglitazone on FIB-4 Index in Indian Patients with Metabolic Dysfunction Related Steatotic Liver Disease: A Real ...

0
196-OR: Utilizing Scalable AI to Revolutionize Type 2 Diabetes Management in Clinical Settings
0

Reading Roadmap196-OR: Utilizing Scalable AI to Revolutionize Type 2 Diabetes Management in Clinical SettingsKey TakeawaysIntroduction: The Intersection of AI ...

0
1969-LB: Early Postpartum Glucose Intolerance and Insulin Deficiency in Women
0

Reading Roadmap1969-LB: Early Postpartum Glucose Intolerance and Insulin Deficiency in WomenKey TakeawaysIntroduction: Unraveling the Complexities of ...

0
Correlation Between Time Below Range and Level 2 Hypoglycemia Rates in Type 1 Diabetes: Findings from DCLP3, DIAMOND, and WISDM Trials
0

Reading RoadmapCorrelation Between Time Below Range and Level 2 Hypoglycemia Rates in Type 1 Diabetes: Findings from DCLP3, DIAMOND, and WISDM TrialsKey ...

0
Hyperglycemia Triggers Increased Lactate Production in the Hypothalamus: Study 1776-LB
0

Reading RoadmapHyperglycemia Triggers Increased Lactate Production in the Hypothalamus: An In-depth Analysis of Study 1776-LBKey TakeawaysIntroduction: ...

0
1635-P: Weight Loss from Survodutide Linked to Altered Food Choices and Dyslipidemia Improvement in Obese Hamsters Fed a Free Choice Diet
0

Reading Roadmap1635-P: Weight Loss from Survodutide Linked to Altered Food Choices and Dyslipidemia Improvement in Obese Hamsters Fed a Free Choice DietKey ...

0
1634-P: Alterations in Bile Acid Circulation in Type 2 Diabetic Rats Post Sleeve Gastrectomy
0

Reading Roadmap1634-P: Unraveling the Changes in Bile Acid Circulation in Type 2 Diabetic Rats Post Sleeve GastrectomyKey TakeawaysIntroduction: A New ...

0
1633-P: Adipocytes Secrete CRISPLD2, Capable of Reducing Adipocyte Size
0

Reading Roadmap1633-P: Adipocytes Secrete CRISPLD2, Capable of Reducing Adipocyte SizeKey TakeawaysIntroduction: Unveiling the Secret of AdipocytesThe Role of ...

0
1632-P: Uncovering New Perspectives in NASH Research through Wild-Derived Chromosome 1 Substitution Strains
0

Reading Roadmap1632-P: Unveiling New Horizons in NASH Research through Wild-Derived Chromosome 1 Substitution StrainsKey TakeawaysIntroduction: A New Frontier ...

0
1631-P: How Cardiac-Specific mGPDH Deficiency Enhances Adipose Tissue Thermogenesis and Combats Obesity through SERPINA1E Secretion
0

Reading Roadmap1631-P: A Revolutionary Approach to Combating Obesity through Enhanced Adipose Tissue ThermogenesisKey TakeawaysIntroduction: A New Frontier in ...

0
1630-P: Exploring the Therapeutic Possibilities of Olfactory Receptor OR51T1 in Treating Obesity
0

Reading Roadmap1630-P: Exploring the Therapeutic Possibilities of Olfactory Receptor OR51T1 in Treating ObesityKey TakeawaysIntroduction: A New Frontier in ...

0
162-OR: Metabolic Dysfunction Linked to Prolonged TNF-a Transcription in Obesity via H3K9/K18 Acetylation
0

Reading Roadmap162-OR: Metabolic Dysfunction Linked to Prolonged TNF-a Transcription in Obesity via H3K9/K18 AcetylationKey TakeawaysIntroduction: Unraveling ...

0
1629-P: STING Disruption’s Protective Effect on Obesity-Related Liver Disease and Insulin Resistance Nullified by Seven-Month High Fat Diet
0

Reading Roadmap1629-P: STING Disruption's Protective Effect on Obesity-Related Liver Disease and Insulin Resistance Nullified by Seven-Month High Fat DietKey ...

0
1628-P: STAT1 Deletion in T-Cells Reduces Obesity and Enhances Insulin Sensitivity in Aging Mice
0

Reading Roadmap1628-P: STAT1 Deletion in T-Cells Reduces Obesity and Enhances Insulin Sensitivity in Aging MiceKey TakeawaysIntroduction: Unraveling the Role ...

0
Novel Compound 1627-P: A Potential Solution for Obesity and Associated Metabolic Disorders Identified through High-Throughput Screening
0

Reading RoadmapNovel Compound 1627-P: A Potential Solution for Obesity and Associated Metabolic Disorders Identified through High-Throughput ScreeningKey ...

0
1626-P: Utilizing ARO-INHBE, an siRNA Therapeutic, for Liver-Specific Suppression of INHBE in Metabolic Diseases Treatment
0

Reading Roadmap1626-P: Harnessing ARO-INHBE, an siRNA Therapeutic, for Liver-Specific Suppression of INHBE in Metabolic Diseases TreatmentKey ...

0
GS-4571: A New Oral GLP-1R Agonist Enhances Glucose Tolerance and Reduces Food Consumption in Obese Diabetic Cynomolgus Monkeys
0

Reading RoadmapGS-4571: A Revolutionary Oral GLP-1R Agonist for Diabetes ManagementKey TakeawaysIntroduction: A New Hope in Diabetes TreatmentUnderstanding ...

0
1624-P: Comparing the Impact of Postoperative Adult Growth Hormone Deficiency and Type 2 Diabetes on Fatty Liver Development
0

Reading Roadmap1624-P: Comparing the Impact of Postoperative Adult Growth Hormone Deficiency and Type 2 Diabetes on Fatty Liver DevelopmentKey ...

0
1623-P: Utilizing QuPATH Artificial Intelligence for Pancreatic Cell Categorization
0

Reading Roadmap1623-P: Harnessing the Power of QuPath Artificial Intelligence for Pancreatic Cell CategorizationKey TakeawaysIntroduction: The Intersection of ...

0
1622-P: Correlation Between Lab Results and Histopathologic Reports of Acute Pancreatitis in nPOD Organ Donors
0

Reading Roadmap1622-P: Correlation Between Lab Results and Histopathologic Reports of Acute Pancreatitis in nPOD Organ DonorsKey TakeawaysIntroduction: ...

0
1261-P: Does Elevated A1C in Elderly Adults with Cognitive and Functional Impairment Provide Sufficient Hypoglycemia Protection?
0

Reading Roadmap1261-P: Does Elevated A1C in Elderly Adults with Cognitive and Functional Impairment Provide Sufficient Hypoglycemia Protection?Key ...

0
Predicting the Impact of Cardiometabolic Diseases on Health Disparities Among Middle-Aged Adults in the U.S.: A Microsimulation Study
0

Reading RoadmapPredicting the Impact of Cardiometabolic Diseases on Health Disparities Among Middle-Aged Adults in the U.S.: A Microsimulation StudyKey ...

0
125-OR: Identifying New Lipid Biomarkers for Deteriorating Glucose Tolerance in Non-Diabetic Kin of Type 2 Diabetes Patients
0

Reading Roadmap125-OR: Identifying New Lipid Biomarkers for Deteriorating Glucose Tolerance in Non-Diabetic Kin of Type 2 Diabetes PatientsKey ...

0
1259-P: Exploring the Connection Between Multiple Risk Factors and Functional Disability in Individuals With and Without Diabetes Mellitus
0

Reading Roadmap1259-P: Unraveling the Link Between Multiple Risk Factors and Functional Disability in Individuals With and Without Diabetes MellitusKey ...

0
1205-P: Analysis of Exocrine Function in Individuals Prone to Type 1 Diabetes
0

Reading Roadmap1205-P: Analysis of Exocrine Function in Individuals Prone to Type 1 DiabetesKey TakeawaysIntroduction: Unraveling the ConnectionExocrine ...

0
1060-P: Enhanced Blood Sugar Regulation and Diabetes Self-Care for Pregnant Patients in Underserved Communities
0

Reading Roadmap1060-P: Enhanced Blood Sugar Regulation and Diabetes Self-Care for Pregnant Patients in Underserved CommunitiesKey TakeawaysIntroduction: The ...

0
1045-P: Evaluating the Cost-Benefit of RSVPreF3 Vaccine with Adjuvant for Diabetic Adults Aged 50-59 in the US
0

Reading RoadmapEvaluating the Cost-Benefit of RSVpreF3 Vaccine with Adjuvant for Diabetic Adults Aged 50-59 in the USKey TakeawaysIntroduction: The Potential ...

0
1044-P: EHR’s Best Practice Advisory Alert Minimizes Hypoglycemia from Insulin Administration in Actual Hospital Environment
0

Reading Roadmap1044-P: EHR's Best Practice Advisory Alert Minimizes Hypoglycemia from Insulin Administration in Actual Hospital EnvironmentKey ...

0
1029-P: Understanding Diabetic Complication Risk through Analysis of Freestyle Libre’s Raw Data
0

Reading Roadmap1029-P: Understanding Diabetic Complication Risk through Analysis of Freestyle Libre's Raw DataKey TakeawaysIntroduction: The Power of Data in ...

0
1016-P: Creating a Highly Precise HPLC Method for Measuring Salivary Glycated Albumin
0

Reading Roadmap1016-P: Creating a Highly Precise HPLC Method for Measuring Salivary Glycated AlbuminKey TakeawaysIntroduction: The Promise of Salivary Glycated ...

0
1007-P: Sustained Glycemic Outcome Improvements in Level2 Members after Two Years
0

Reading Roadmap1007-P: Sustained Glycemic Outcome Improvements in Level2 Members after Two YearsKey TakeawaysIntroduction: The Power of Digital Health ...

0
Patient Satisfaction and Time in Range Outcomes after 16 Weeks of iGlarLixi Treatment in Insulin-Naive Adults with Poorly Controlled Type 2 Diabetes
0

Reading RoadmapPatient Satisfaction and Time in Range Outcomes after 16 Weeks of iGlarLixi Treatment in Insulin-Naive Adults with Poorly Controlled Type 2 ...

0
838-P: The Effect of Age on the Performance and Safety of Weekly Insulin Icodec Versus Daily Insulin for Type 2 Diabetes (ONWARDS 1-5)
0

Reading Roadmap838-P: The Effect of Age on the Performance and Safety of Weekly Insulin Icodec Versus Daily Insulin for Type 2 Diabetes (ONWARDS 1-5)Key ...

0
837-P: Enhanced Glycemic Control in Pediatric Type 1 Diabetes Patients through Closed-Loop Insulin Delivery: A Systematic Review
0

Reading Roadmap837-P: Enhanced Glycemic Control in Pediatric Type 1 Diabetes Patients through Closed-Loop Insulin Delivery: A Systematic ReviewKey ...

0
836-P: Compliance with App-Guided Dosage for Weekly Insulin Icodec in Insulin-Newbie Type 2 Diabetes – A Post Hoc Review of ONWARDS 5
0

Reading Roadmap836-P: Compliance with App-Guided Dosage for Weekly Insulin Icodec in Insulin-Newbie Type 2 Diabetes - A Post Hoc Review of ONWARDS 5Key ...

0
835-P: Unconventional Pancreatogenic Diabetes – Treatment Experiences of Patients Post-Pancreatectomy
0

Reading Roadmap835-P: Unconventional Pancreatogenic Diabetes - Treatment Experiences of Patients Post-PancreatectomyKey TakeawaysIntroduction: Understanding ...

0
834-P: An Examination of Transitioning from Basal Insulin to Insulin Degludec/Insulin Aspart in Type 2 Diabetes Patients with Lower FPG Levels than HbA1c Predictions
0

Reading Roadmap834-P: An Examination of Transitioning from Basal Insulin to Insulin Degludec/Insulin Aspart in Type 2 Diabetes Patients with Lower FPG Levels ...

0
833-P: Global Survey Reveals Attitudes and Insights about Basal Insulin from People with Type 2 Diabetes
0

Reading Roadmap833-P: Global Survey Reveals Attitudes and Insights about Basal Insulin from People with Type 2 DiabetesKey TakeawaysIntroduction: Unveiling the ...

0
832-P: Desired Characteristics of Weekly Insulin by Individuals with Type 2 Diabetes
0

Reading Roadmap832-P: Desired Characteristics of Weekly Insulin by Individuals with Type 2 DiabetesKey TakeawaysIntroduction: The Potential of Weekly ...

0
831-P: Desired Features of Weekly Insulin by Individuals with Type 1 Diabetes
0

Reading Roadmap831-P: Desired Features of Weekly Insulin by Individuals with Type 1 DiabetesKey TakeawaysIntroduction: The Potential of Weekly InsulinImproved ...

0
830-P: Weekly Insulin Icodec vs. Daily Basal Insulin: No Increased Hypoglycemia from Physical Activity in Type 2 Diabetes—ONWARDS 1–5
0

Reading Roadmap830-P: Weekly Insulin Icodec vs. Daily Basal Insulin: No Increased Hypoglycemia from Physical Activity in Type 2 Diabetes—ONWARDS 1–5Key ...

0
Correlation of Diabetic Complications and Comorbidities with Major Cardiovascular Events in Type 2 Diabetes: A Danish Registry-Based Case-Control Study Over Time
0

Reading RoadmapCorrelation of Diabetic Complications and Comorbidities with Major Cardiovascular Events in Type 2 Diabetes: A Danish Registry-Based ...

0
Comparative Study on Glycemic Results: Rapid Insulin vs Ultrarapid Insulin in Omnipod 5 (OP5)
0

Reading RoadmapComparative Study on Glycemic Results: Rapid Insulin vs Ultrarapid Insulin in Omnipod 5 (OP5)Key TakeawaysIntroduction: The Battle of Insulins ...

0
827-P: Efficacy and Security of Human Insulin Therapy in Aged Type 2 Diabetes Patients
0

Reading Roadmap827-P: Efficacy and Security of Human Insulin Therapy in Aged Type 2 Diabetes PatientsKey TakeawaysIntroduction: The Role of Insulin Therapy in ...

0
Comparative Study on the Efficacy and Safety of Once-Weekly Insulin Icodec and Once-Daily Basal Insulin in Type 2 Diabetes Patients Based on Kidney Function – ONWARDS 1-5
0

Reading RoadmapComparative Study on the Efficacy and Safety of Once-Weekly Insulin Icodec and Once-Daily Basal Insulin in Type 2 Diabetes Patients Based on ...

0
825-P: Analysis of Insulin Efsitora Alfa (Efsitora) Pharmacokinetics Following Subcutaneous Administration at Various Injection Locations
0

Reading Roadmap825-P: Analysis of Insulin Efsitora Alfa (Efsitora) Pharmacokinetics Following Subcutaneous Administration at Various Injection LocationsKey ...

0
824-P: Weekly Insulin Icodec vs. Daily Basal Insulin: No Increased Hypoglycemia from Physical Activity in Type 1 Diabetes—ONWARDS 6
0

Reading Roadmap824-P: Weekly Insulin Icodec vs. Daily Basal Insulin: No Increased Hypoglycemia from Physical Activity in Type 1 Diabetes—ONWARDS 6Key ...

0
823-P: Understanding the Molecular and Pharmacological Characteristics of GZR4, a Weekly Insulin Analog
0

Reading Roadmap823-P: Understanding the Molecular and Pharmacological Characteristics of GZR4, a Weekly Insulin AnalogKey TakeawaysIntroduction: A New Frontier ...

0
822-P: Comparing the Impact of NNC-965 and Insulin Glargine (IGla) on Heart Structure and Function
0

Reading Roadmap822-P: Comparing the Impact of NNC-965 and Insulin Glargine (IGla) on Heart Structure and FunctionKey TakeawaysIntroduction: The Role of NNC-965 ...

0
821-P: Cross-Sectional Study Comparing In-Hospital Glucose Management in Type 2 Diabetes Patients: AI Chatbot vs. Physicians
0

Reading Roadmap821-P: Cross-Sectional Study Comparing In-Hospital Glucose Management in Type 2 Diabetes Patients: AI Chatbot vs. PhysiciansKey ...

0
Comparison of Faster-Acting Insulin Aspart and Insulin Aspart in Adults with Type 1 Diabetes Using Insulin Pump and Continuous Glucose Monitoring
0

Reading RoadmapComparison of Faster-Acting Insulin Aspart and Insulin Aspart in Adults with Type 1 Diabetes Using Insulin Pump and Continuous Glucose ...

0
81-OR: Evaluating Different Screening Methods for Advanced Fibrosis from MASLD in Diabetic Patients
0

Reading Roadmap81-OR: Evaluating Different Screening Methods for Advanced Fibrosis from MASLD in Diabetic PatientsKey TakeawaysIntroduction: The Importance of ...

0
819-P: Introducing GZR101, A New Premix Insulin for Diabetes Control
0

Reading Roadmap819-P: Introducing GZR101, A New Premix Insulin for Diabetes ControlKey TakeawaysIntroduction: A New Era in Diabetes ManagementThe Innovation of ...

0
818-P: Comparing the Impact of Insulin Efsitora Alfa and Glargine on Hypoglycemia Frequency and Severity under High-Risk Conditions in Type 2 Diabetes Patients
0

Reading Roadmap818-P: Comparing the Impact of Insulin Efsitora Alfa and Glargine on Hypoglycemia Frequency and Severity under High-Risk Conditions in Type 2 ...

0
817-P: Comparative Analysis of Demographic, Clinical, and Treatment Traits in Patients with Prompt vs. Postponed Basal Insulin Initiation
0

Reading Roadmap817-P: Comparative Analysis of Demographic, Clinical, and Treatment Traits in Patients with Prompt vs. Postponed Basal Insulin InitiationKey ...

0
816-P: Comparing Health Care Resource Use and Expenses Between Timely and Delayed Initiation of Basal Insulin
0

Reading Roadmap816-P: Comparing Health Care Resource Use and Expenses Between Timely and Delayed Initiation of Basal InsulinKey TakeawaysIntroduction: The ...

0
815-P: Evaluating the Effectiveness of Identified Predictors for Over 15% Body Weight Reduction using Tirzepatide in Type 2 Diabetes Patients in SURMOUNT-2 Study
0

Reading Roadmap815-P: Evaluating the Effectiveness of Identified Predictors for Over 15% Body Weight Reduction using Tirzepatide in Type 2 Diabetes Patients in ...

0
814-P: Identifying Early Selection Indicators of GLP-1 Receptor Agonists in Real-World Data for Japanese Type 2 Diabetes Patients
0

Reading Roadmap814-P: Identifying Early Selection Indicators of GLP-1 Receptor Agonists in Real-World Data for Japanese Type 2 Diabetes PatientsKey ...

0
813-P: Effective Application of Hybrid Closed Loop Insulin Pumps and GLP1 Agonists in Managing Diabulimia and Eating Disorders in Type 1 Diabetes Patients
0

Reading Roadmap813-P: Effective Application of Hybrid Closed Loop Insulin Pumps and GLP1 Agonists in Managing Diabulimia and Eating Disorders in Type 1 ...

0
812-P: Evaluating the Safety and Effectiveness of Early GLP1RA and SGLT2 Inhibitors Use in Post-Kidney Transplant Patients with Type 2 Diabetes
0

Reading Roadmap812-P: Evaluating the Safety and Effectiveness of Early GLP1RA and SGLT2 Inhibitors Use in Post-Kidney Transplant Patients with Type 2 ...

0
811-P: Evaluating the Safety and Efficacy of iGlarLixi for Type 2 Diabetes Patients in South Korea
0

Reading Roadmap811-P: Evaluating the Safety and Efficacy of iGlarLixi for Type 2 Diabetes Patients in South KoreaKey TakeawaysIntroduction: The Rising ...

0
The Impact of Glucagon-Like-Peptide-1 Agonists on Overweight/Obese Adults with Type 1 Diabetes: A Retrospective Study from Saudi Arabia, 2023
0

Reading RoadmapThe Impact of Glucagon-Like-Peptide-1 Agonists on Overweight/Obese Adults with Type 1 Diabetes: A Retrospective Study from Saudi Arabia, 2023Key ...

0
The Link Between Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Cardiovascular Disease: A Study on Mortality Rates in Type 2 Diabetes Patients
0

Reading RoadmapThe Link Between Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Cardiovascular Disease: A Study on Mortality Rates in Type 2 Diabetes ...

0
12-Month Follow-Up Study on Oral Semaglutide Treatment in Indian Patients with Type 2 Diabetes Mellitus (SOLID 809-P)
0

Reading Roadmap12-Month Follow-Up Study on Oral Semaglutide Treatment in Indian Patients with Type 2 Diabetes Mellitus (SOLID 809-P)Key TakeawaysIntroduction: ...

0
808-P: The Effect of Fasting on Compliance with Dosing Guidelines and Effectiveness of Oral Semaglutide in Type 2 Diabetes Patients during Ramadan: A Real-World Subanalysis of O-SEMA-Fast
0

Reading Roadmap808-P: The Effect of Fasting on Compliance with Dosing Guidelines and Effectiveness of Oral Semaglutide in Type 2 Diabetes Patients during ...

0
807-P: The Impact of GLP-1 Agonists on Delayed Gastric Emptying During Elective Eye Surgeries
0

Reading Roadmap807-P: The Impact of GLP-1 Agonists on Delayed Gastric Emptying During Elective Eye SurgeriesKey TakeawaysIntroduction: Unveiling the Impact of ...

User Articles: Diane Caldwell
Sorry. Author have no articles yet
User Deals: Diane Caldwell
Sorry. Author have no deals yet
Browsing All Comments By: Diane Caldwell
Diabetes Compass
Logo
Compare items
  • Cameras (0)
  • Phones (0)
Compare